Retinoid X Receptor Gamma (RXRγ; NR2B3)
|Product Family||Product Number||Product Description||Technical Manual|
|IB00821-32||Human RXRγ Reporter Assay System, 3 x 32 assays in 96-well format||Technical Manual|
|IB00821||Human RXRγ Reporter Assay System, 1 x 96-well format assays||Technical Manual|
|IB00822||Human RXRγ Reporter Assay System, 1 x 384-well format assays||Technical Manual|
Retinoid X Receptor Gamma Assay Kit
This Retinoid X Receptor Gamma (RXRγ) assay kit is an all-inclusive firefly luciferase reporter assay system that includes, in addition to RXRγ Reporter Cells, two optimized media for use during cell culture and (optionally) in diluting the test samples, a reference agonist, Luciferase Detection Reagent, a cell culture-ready assay plate, and a detailed protocol.
INDIGO’s cell-based reporter assays allow scientists to detect any biological activity that their test samples may exert against a specific receptor present in the cell. They utilize firefly luciferase reporter gene technology which provides superior precision and sensitivity. Since the receptor binding controls the expression of the luciferase reporter gene, luciferase activity in the cells can be correlated directly with the activity of the receptor. The strength of an interaction of a chemical with the target receptor is quantified using a luminometer to measure the level of light emitted.
Fast, reproducible, easy-to-analyze results are only four steps away
Many luciferase reporter assays require the user to grow their own cells and take time to optimize the results. INDIGO’s reporter cells contain the receptor of interest and the luciferase reporter gene. Reporter cells have been optimized to provide extreme sensitivity to quantify even small changes in receptor activity. With INDIGO’s cell-based reporter assays, the process is as easy as Thaw, Feed, Dose, and Read.
RXRγ Reporter Cells
RXRγ Reporter Cells are prepared using INDIGO’s proprietary CryoMite™ process. This proprietary cryopreservation process, enables long-term preservation of our unique reporter cells, so we can ship our cryopreserved reporter cells and assay reagents to you via overnight delivery, for your immediate use. Or, you can store the assay kits at -80°C. Once thawed, reporter cells are ready for immediate use so there is no need to take time on intermediate spin-and-wash steps, viability determinations, or cell titer adjustments.
RXRγ Luciferase Reporter
INDIGO’s RXRγ assay kits feature a luciferase detection reagent specially formulated to provide stable light emission between 5 and 90+ minutes after initiating the luciferase reaction. Incorporating a 5-minute reaction-rest period ensures that light emission profiles attain maximal stability, thereby allowing assay plates to be processed in batch. By doing so, the signal output from all sample wells, from one plate to the next, may be directly compared within an experimental set.
Bulk assay reagents can be custom manufactured to accommodate any scale of HTS. Please inquire.
Retinoid X Receptor Gamma Assay Services
The primary application of INDIGO’s cell-based nuclear receptor assays are to quantitatively assess the bioactivity of a test compound as an agonist (activator) or antagonist (inhibition of an agonist response) of a given receptor. Service assays include a positive control reference compound and ‘vehicle’ control for every experiment. A formal study report and all data files are provided to the client upon completion of the study. To receive a quote for your proposed study, complete & submit the online “Request a Quote” form or contact an INDIGO Customer Service Representative to discuss your desired study parameters.
Retinoid X Receptor Gamma Background
Retinoid X receptor gamma (RXR-gamma), also known as NR2B3 is a nuclear receptor which in humans is encoded by the RXRG gene. Retinoid X receptors (RXRs) and retinoic acid receptors (RARs), are nuclear receptors that mediate the biological effects of retinoids by their involvement in retinoic acid-mediated gene activation. These receptors exert their action by binding, as homodimers or heterodimers, to specific sequences in the promoters of target genes and regulating their transcription. The protein encoded by this gene is a member of the steroid and thyroid hormone receptor superfamily of transcription factors.
INDIGO’s Human Retinoid X Receptor, Gamma (RXRγ) Reporter Assay System utilizes proprietary mammalian cells engineered to provide constitutive, high-level expression of human RXRγ (NR2B3), a ligand-dependent transcription factor. Because these cells incorporate a responsive luciferase reporter gene, quantifying expressed luciferase activity provides a sensitive surrogate measure of RXRγ activity in treated cells.
The primary application of this reporter assay system is in the screening of test samples to quantify functional activity, either agonist or antagonist, that they may exert against human RXRγ.
For more information on RXRγ, visit the Nuclear Receptor Resource.
Synonyms: Retinoid X Receptor Gamma , RXRγ, RXR Gamma , RXRg, Human Retinoid X Receptor Gamma , hRXRγ, NR2B3
Retinoid X Receptor Gamma Assay Data
Agonist and Antagonist dose-response analyses of the Human RXRγ. A.) Analyses of RXRγ Reporter Cells using the reference agonists 9-cis-Retinoic Acid (provided). B.) Analyses of RXRγ antagonist dose-responses using HX531 and UVI3003 (Tocris). Assay setups and quantification of RXRγ activities were performed following the protocol provided in the assay Technical Manual. Luminescence was quantified and average relative light units (RLU) and corresponding standard deviation (SD) values were determined for each treatment concentration (n ≥ 4). Values of Fold-activation and Z’ were calculated as described by Zhang, et al. (1999). Non-linear regression and EC50 analyses were performed using GraphPad Prism software. High S/B and Z' scores confirm the robust performance of this RXRγ Assay.
Retinoid X Receptor Gamma Assay Research Areas
Diabetes; Cancer; Autoimmune Disease; Psoriasis; Reproduction and Development; Retinoid Panel